Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-28

FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Novo Nordisk's insulin aspart protamine and insulin aspart mix 70/30.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 (insulin aspart protamine and insulin aspart mix 70/30)

Snippet

SUPPL AP for INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 (INSULIN ASPART)